TOFACITINIB CITRATE | A217299 | MSN LABORATORIES PRIVATE LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Pfizer Inc. et al v. MSN Laboratories Private Ltd. 3 patentsANDA 217299, 217298tofacitinib citrate | D. Del. | 2022-06-06 | Terminated 2022-08-24 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.
Tofacitinib citrate (NDA 217299) received FDA approval for a new product formulation or indication under applicant MSN.
New: New record
Tofacitinib citrate (ANDA 217299, Applicant Segment 002) was added to the FDA product database.
New: New record